Cellular mechanism of vasoconstriction induced by angiotensin II: it remains to be determined.
Kanaide
Hideo
H
Ichiki
Toshihiro
T
Nishimura
Junji
J
Hirano
Katsuya
K
D000804:Angiotensin II / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D001012:Aorta, Abdominal / Q000187:drug effects / Q000502:physiology; D002118:Calcium / Q000378:metabolism; D005263:Femoral Artery / Q000187:drug effects / Q000502:physiology; D043802:GTP-Binding Protein alpha Subunits, Gq-G11 / Q000378:metabolism; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D018994:Myosin Light Chains / Q000378:metabolism; D009219:Myosin-Light-Chain Kinase / Q000378:metabolism; D010766:Phosphorylation; D011817:Rabbits; D044140:Receptor, Angiotensin, Type 1 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D013997:Time Factors; D010738:Type C Phospholipases / Q000378:metabolism; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology*
D018994:Myosin Light Chains; D044140:Receptor, Angiotensin, Type 1; D000804:Angiotensin II; D009219:Myosin-Light-Chain Kinase; D010738:Type C Phospholipases; D043802:GTP-Binding Protein alpha Subunits, Gq-G11; D002118:Calcium